跳至主要内容
临床试验/NCT03839888
NCT03839888已完成不适用

Short Term Refractive and Ocular Parameter Changes After Topical Atropine

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation0 个研究点目标入组 96 人开始时间: 2015年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
96
主要终点
SER

研究概览

简要总结

In order we had designed a prospective clinical trial. Spherical equivalent refractive error (SER), axial length (AL), mean keratometric value (Mean-K), anterior chamber depth (ACD), and intraocular pressure (IOP) were measured at baseline and one week after topical use of 0.125% atropine. Postcycloplegic changes of refractive error and ocular parameters were evaluated, and their correlations were analyzed with multiple linear regression models.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who had an SER of -0.5 diopters or less in their eyes.

排除标准

  • Patients who had already been undergoing cycloplegic treatment for myopia before.

研究组 & 干预措施

0.125% atropine group

Experimental

patients used the 0.125 % atropine eyedrop every night before sleep for 7 days

干预措施: 0.125% Atropine (Drug)

结局指标

主要结局

SER

时间窗: change from SER at 7 days

Spherical equivalent refractive error

次要结局

  • AL(change from AL at 7 days)
  • ACD(change from ACD at 7 days)
  • IOP(change from IOP at 7 days)

研究者

申办方类型
Other
责任方
Sponsor

相似试验